Compare Jakarta Setiabudi Internasional Tbk (JSPT) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jakarta Setiabudi Internasional Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Jakarta Setiabudi Internasional Tbk trades at Rp1,500 (market cap 3.22T, 73K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jakarta Setiabudi Internasional Tbk is far larger — about 30.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| JSPT | SCPI | |
|---|---|---|
Market Cap | 3.22T | 104.4B |
Volume | 73K | — |
Lot | 730 | — |
Turnover | 108M | — |
Average Price | 1,479.5 | — |
Value | 108M | — |
Indicative Equilibrium Price | 1,500 | — |
Indicative Equilibrium Volume | 297 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jakarta Setiabudi Internasional Tbk
PT. Jakarta Setiabudi Internasional Tbk (the Company) was established in the Republic of Indonesia within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on Notarial Deed No. 4 dated July 2, 1975 of Imas Fatimah, S.H., as amended by Notarial Deed No. 15 dated September 11, 1975 of the same notary. At the first time until 1996 this company was focusing in construction. Leasing and office building maintanance and apartment surrounding Kuningan area, Jakarta.
Read more on JSPT →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
